{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:21:18Z","timestamp":1791584478342,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10787-025-01947-z","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:25:44Z","timestamp":1758648344000},"page":"5757-5768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Resveratrol: potential therapeutic effects on ocular health"],"prefix":"10.1007","volume":"33","author":[{"given":"Bennett Kurien","family":"Biju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-5420","authenticated-orcid":false,"given":"Marina","family":"Andavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"1947_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm92040059","author":"G Accomasso","year":"2024","unstructured":"Accomasso G, Turku F, Sapino S, Chirio D, Peira E, Gallarate M (2024) Resveratrol: extraction techniques, bioactivity, and therapeutic potential in ocular diseases. Sci Pharm. https:\/\/doi.org\/10.3390\/scipharm92040059","journal-title":"Sci Pharm"},{"key":"1947_CR2","first-page":"2783","volume":"24","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783\u20132840","journal-title":"Anticancer Res"},{"key":"1947_CR3","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1021\/JF9042858","volume":"58","author":"I Alfaras","year":"2010","unstructured":"Alfaras I, P\u00e9rez M, Juan ME, Merino G, Prieto JG, Planas JM, \u00c1lvarez AI (2010) Involvement of breast cancer resistance protein (BCRP1\/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice. J Agric Food Chem 58:4523\u20134528. https:\/\/doi.org\/10.1021\/JF9042858","journal-title":"J Agric Food Chem"},{"key":"1947_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2011.09.083","volume":"158","author":"A Amri","year":"2012","unstructured":"Amri A, Chaumeil JC, Sfar S, Charrueau C (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158:182\u2013193. https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.083","journal-title":"J Control Release"},{"key":"1947_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/DTI.S9442","volume":"2012","author":"B Annabi","year":"2012","unstructured":"Annabi B, Lord-Dufour S, V\u00e9zina A, B\u00e9liveau R (2012) Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is sirt1-independent. Drug Target Insights 2012:1\u201311. https:\/\/doi.org\/10.4137\/DTI.S9442","journal-title":"Drug Target Insights"},{"key":"1947_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMRA1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227\u20131239. https:\/\/doi.org\/10.1056\/NEJMRA1005073","journal-title":"N Engl J Med"},{"key":"1947_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/NRD2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493\u2013506. https:\/\/doi.org\/10.1038\/NRD2060","journal-title":"Nat Rev Drug Discov"},{"key":"1947_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/FJC.0b013e3181bfaff3","volume":"54","author":"AAA Bertelli","year":"2009","unstructured":"Bertelli AAA, Das DK (2009) Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54:468\u2013476. https:\/\/doi.org\/10.1097\/FJC.0b013e3181bfaff3","journal-title":"J Cardiovasc Pharmacol"},{"key":"1947_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejphar.2011.05.026","volume":"667","author":"SR Bhatt","year":"2011","unstructured":"Bhatt SR, Lokhandwala MF, Banday AA (2011) Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol 667:258\u2013264. https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.026","journal-title":"Eur J Pharmacol"},{"key":"1947_CR10","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1074\/JBC.M501250200","volume":"280","author":"MT Borra","year":"2005","unstructured":"Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280:17187\u201317195. https:\/\/doi.org\/10.1074\/JBC.M501250200","journal-title":"J Biol Chem"},{"key":"1947_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/J.CELLSIG.2017.09.019","volume":"40","author":"YC Chang","year":"2017","unstructured":"Chang YC, Lin CW, Hsieh MC, Wu HJ, Wu WS, Wu WC, Kao YH (2017) High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells. Cell Signal 40:248\u2013257. https:\/\/doi.org\/10.1016\/J.CELLSIG.2017.09.019","journal-title":"Cell Signal"},{"key":"1947_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/J.EXER.2018.11.023","volume":"181","author":"Y Chen","year":"2019","unstructured":"Chen Y, Meng J, Li H, Wei H, Bi F, Liu S, Tang K, Guo H, Liu W (2019) Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1. Exp Eye Res 181:356\u2013366. https:\/\/doi.org\/10.1016\/J.EXER.2018.11.023","journal-title":"Exp Eye Res"},{"key":"1947_CR13","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/1940-6207.CAPR-09-0155","volume":"3","author":"HHS Chow","year":"2010","unstructured":"Chow HHS, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS (2010) Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res 3:1168\u20131175. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-09-0155","journal-title":"Cancer Prev Res"},{"key":"1947_CR14","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/J.EXER.2008.10.004","volume":"88","author":"AF Clark","year":"2009","unstructured":"Clark AF, Wordinger RJ (2009) The role of steroids in outflow resistance. Exp Eye Res 88:752\u2013759. https:\/\/doi.org\/10.1016\/J.EXER.2008.10.004","journal-title":"Exp Eye Res"},{"key":"1947_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.focha.2023.100539","author":"T Constantinescu","year":"2023","unstructured":"Constantinescu T, Mihis AG (2023) Resveratrol as a privileged molecule with antioxidant activity. Food Chem Adv. https:\/\/doi.org\/10.1016\/j.focha.2023.100539","journal-title":"Food Chem Adv"},{"key":"1947_CR16","doi-asserted-by":"publisher","first-page":"H2721","DOI":"10.1152\/AJPHEART.00235.2008","volume":"294","author":"A Csiszar","year":"2008","unstructured":"Csiszar A, Labinskyy N, Podlutsky A, Kaminski PM, Wolin MS, Zhang C, Mukhopadhyay P, Pacher P, Hu F, De Cabo R, Ballabh P, Ungvari Z (2008) Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 294:H2721. https:\/\/doi.org\/10.1152\/AJPHEART.00235.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1947_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/MNFR.200500022","volume":"49","author":"CA De La Lastra","year":"2005","unstructured":"De La Lastra CA, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49:405\u2013430. https:\/\/doi.org\/10.1002\/MNFR.200500022","journal-title":"Mol Nutr Food Res"},{"key":"1947_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/J.NEUROSCIENCE.2009.01.017","volume":"159","author":"D Della-Morte","year":"2009","unstructured":"Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993\u20131002. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2009.01.017","journal-title":"Neuroscience"},{"key":"1947_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/J.1749-6632.2010.05871.X","volume":"1215","author":"D Delmas","year":"2011","unstructured":"Delmas D, Aires V, Limagne E, Dutartre P, Mazu\u00e9 F, Ghiringhelli F, Latruffe N (2011) Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci 1215:48\u201359. https:\/\/doi.org\/10.1111\/J.1749-6632.2010.05871.X","journal-title":"Ann N Y Acad Sci"},{"key":"1947_CR20","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/J.BBAMCR.2015.08.012","volume":"1853","author":"B Dib","year":"2015","unstructured":"Dib B, Lin H, Maidana DE, Tian B, Miller JB, Bouzika P, Miller JW, Vavvas DG (2015) Mitochondrial DNA has a pro-inflammatory role in AMD. Biochim Biophys Acta (BBA) Mol Cell Res 1853:2897\u20132906. https:\/\/doi.org\/10.1016\/J.BBAMCR.2015.08.012","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"1947_CR21","doi-asserted-by":"publisher","first-page":"e49761","DOI":"10.1371\/JOURNAL.PONE.0049761","volume":"7","author":"M Gertz","year":"2012","unstructured":"Gertz M, Nguyen GTT, Fischer F, Suenkel B, Schlicker C, Fr\u00e4nzel B, Tomaschewski J, Aladini F, Becker C, Wolters D, Steegborn C (2012) A molecular mechanism for direct sirtuin activation by resveratrol. PLoS ONE 7:e49761. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0049761","journal-title":"PLoS ONE"},{"key":"1947_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ma17061420","author":"J Gonzalez-Perez","year":"2024","unstructured":"Gonzalez-Perez J, Lopera-Echavarr\u00eda AM, Arevalo-Alquichire S, Araque-Mar\u00edn P, Londo\u00f1o ME (2024) Development of a resveratrol nanoformulation for the treatment of diabetic retinopathy. Materials. https:\/\/doi.org\/10.3390\/ma17061420","journal-title":"Materials"},{"key":"1947_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1934578X0900400503","volume":"4","author":"RF Guerrero","year":"2009","unstructured":"Guerrero RF, Garc\u00eda-Parrilla MC, Puertas B, Cantos-Villar E (2009) Wine, resveratrol and health: a review. Nat Prod Commun 4:635\u2013658. https:\/\/doi.org\/10.1177\/1934578X0900400503","journal-title":"Nat Prod Commun"},{"key":"1947_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/CARCIN\/22.8.1111","volume":"22","author":"J Gusman","year":"2001","unstructured":"Gusman J, Malonne H, Atassi G (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22:1111\u20131117. https:\/\/doi.org\/10.1093\/CARCIN\/22.8.1111","journal-title":"Carcinogenesis"},{"key":"1947_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/NATURE01960","volume":"425","author":"KT Howitz","year":"2003","unstructured":"Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191\u2013196. https:\/\/doi.org\/10.1038\/NATURE01960","journal-title":"Nature"},{"key":"1947_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/SCIENCE.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218\u2013220. https:\/\/doi.org\/10.1126\/SCIENCE.275.5297.218","journal-title":"Science"},{"key":"1947_CR27","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/j.fct.2011.08.023","volume":"49","author":"WD Johnson","year":"2011","unstructured":"Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M, McCormick DL (2011) Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol 49:3319\u20133327. https:\/\/doi.org\/10.1016\/j.fct.2011.08.023","journal-title":"Food Chem Toxicol"},{"key":"1947_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/S00280-010-1525-4","volume":"68","author":"IM Kapetanovic","year":"2011","unstructured":"Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68:593\u2013601. https:\/\/doi.org\/10.1007\/S00280-010-1525-4","journal-title":"Cancer Chemother Pharmacol"},{"key":"1947_CR29","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.3390\/molecules30153262","volume":"30","author":"S Ka\u0161telan","year":"2025","unstructured":"Ka\u0161telan S, Konjevoda S, Sari\u0107 A, Urli\u0107 I, Lovri\u0107 I, \u010canovi\u0107 S, Mateji\u0107 T, \u0160e\u0161elja Peri\u0161in A (2025) Resveratrol as a novel therapeutic approach for diabetic retinopathy: molecular mechanisms, clinical potential, and future challenges. Molecules 30:3262. https:\/\/doi.org\/10.3390\/molecules30153262","journal-title":"Molecules"},{"issue":"10","key":"1947_CR30","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1091\/MBC.10.10.3125","volume":"10","author":"S Kim","year":"1999","unstructured":"Kim S, Benguria A, Lai CY, Jazwinski SM (1999) Modulation of life-span by histone deacetylase genes in Saccharomyces cerevisiae. Mol Biol Cell 10(10):3125\u20133136. https:\/\/doi.org\/10.1091\/MBC.10.10.3125","journal-title":"Mol Biol Cell"},{"key":"1947_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/J.BBRC.2011.10.115","volume":"415","author":"SW Kim","year":"2011","unstructured":"Kim SW, Kim CE, Kim MH (2011) Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochem Biophys Res Commun 415:602\u2013607. https:\/\/doi.org\/10.1016\/J.BBRC.2011.10.115","journal-title":"Biochem Biophys Res Commun"},{"key":"1947_CR32","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","volume":"1852","author":"RA Kowluru","year":"2015","unstructured":"Kowluru RA, Mishra M (2015) Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis 1852:2474\u20132483. https:\/\/doi.org\/10.1016\/j.bbadis.2015.08.001","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1947_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2165\/11531820-000000000-00000","volume":"49","author":"C La Porte","year":"2010","unstructured":"La Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N, Cameron DW (2010) Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet 49:449\u2013454. https:\/\/doi.org\/10.2165\/11531820-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"1947_CR34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/J.BBRC.2004.02.164","volume":"316","author":"A Lan\u00e7on","year":"2004","unstructured":"Lan\u00e7on A, Delma D, Osman H, Th\u00e9not JP, Jannin B, Latruffe N (2004) Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun 316:1132\u20131137. https:\/\/doi.org\/10.1016\/J.BBRC.2004.02.164","journal-title":"Biochem Biophys Res Commun"},{"key":"1947_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF02124034","volume":"33","author":"P Langcake","year":"1977","unstructured":"Langcake P, Pryce RJ (1977) A new class of phytoalexins from grapevines. Experientia 33:151\u2013152. https:\/\/doi.org\/10.1007\/BF02124034","journal-title":"Experientia"},{"key":"1947_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.pbr.2015.05.005","volume":"220","author":"H Levkovitch-Verbin","year":"2015","unstructured":"Levkovitch-Verbin H (2015) Retinal ganglion cell apoptotic pathway in glaucoma: initiating and downstream mechanisms. Prog Brain Res 220:37\u201357. https:\/\/doi.org\/10.1016\/bs.pbr.2015.05.005","journal-title":"Prog Brain Res"},{"key":"1947_CR37","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.neurobiolaging.2014.12.021","volume":"36","author":"JD Lindsey","year":"2015","unstructured":"Lindsey JD, Duong-Polk KX, Hammond D, Leung CK, Weinreb RN (2015) Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol. Neurobiol Aging 36:1969\u20131981. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.021","journal-title":"Neurobiol Aging"},{"key":"1947_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/S-0030-1248725","volume":"36","author":"G Lippi","year":"2010","unstructured":"Lippi G, Franchini M, Favaloro EJ, Targher G (2010) Moderate red wine consumption and cardiovascular disease risk: beyond the French Paradox. Semin Thromb Hemost 36:59\u201370. https:\/\/doi.org\/10.1055\/S-0030-1248725","journal-title":"Semin Thromb Hemost"},{"key":"1947_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/JOP.2012.0141","volume":"29","author":"XQ Liu","year":"2013","unstructured":"Liu XQ, Wu BJ, Pan WHT, Zhang XM, Liu JH, Chen MM, Chao FP, Chao HM (2013) Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther 29:33\u201340. https:\/\/doi.org\/10.1089\/JOP.2012.0141","journal-title":"J Ocul Pharmacol Ther"},{"key":"1947_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/etm.2015.2877","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, Lin Y, Liu X (2016) Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression. Exp Ther Med 11:257\u2013262. https:\/\/doi.org\/10.3892\/etm.2015.2877","journal-title":"Exp Ther Med"},{"key":"1947_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/J.FCT.2008.10.029","volume":"47","author":"C Luna","year":"2009","unstructured":"Luna C, Li G, Liton PB, Qiu J, Epstein DL, Challa P, Gonzalez P (2009) Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol 47:198\u2013204. https:\/\/doi.org\/10.1016\/J.FCT.2008.10.029","journal-title":"Food Chem Toxicol"},{"key":"1947_CR42","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/S11095-006-9060-Z","volume":"23","author":"A Maier-Salamon","year":"2006","unstructured":"Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, J\u00e4ger W (2006) Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res 23:2107\u20132115. https:\/\/doi.org\/10.1007\/S11095-006-9060-Z","journal-title":"Pharm Res"},{"key":"1947_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/MET.2014.0082","volume":"12","author":"M M\u00e9ndez-Del Villar","year":"2014","unstructured":"M\u00e9ndez-Del Villar M, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, P\u00e9rez-Rubio KG, Liz\u00e1rraga-Valdez R (2014) Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord 12:497\u2013501. https:\/\/doi.org\/10.1089\/MET.2014.0082","journal-title":"Metab Syndr Relat Disord"},{"key":"1947_CR45","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/S00018-011-0850-Z","volume":"69","author":"G Mud\u00f2","year":"2012","unstructured":"Mud\u00f2 G, M\u00e4kel\u00e4 J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, M\u00e4lki\u00e4 A, Bonomo A, Kairisalo M, Aguirre JA, Korhonen L, Belluardo N, Lindholm D (2012) Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinsons disease. Cell Mol Life Sci 69:1153\u20131165. https:\/\/doi.org\/10.1007\/S00018-011-0850-Z","journal-title":"Cell Mol Life Sci"},{"key":"1947_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.CANLET.2007.11.008","volume":"261","author":"M Murias","year":"2008","unstructured":"Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W (2008) Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261:172\u2013182. https:\/\/doi.org\/10.1016\/J.CANLET.2007.11.008","journal-title":"Cancer Lett"},{"key":"1947_CR47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1248\/yakushi1947.83.10_988","volume":"83","author":"S Nonomura","year":"1963","unstructured":"Nonomura S, Kanagawa H, Makimoto A (1963) Chemical constituents of Polygonaceous plants. I. Studies on the components of KO-J O-KON. (Polygonum cuspidatum Sieb. et Zucc.). Yakugaku Zasshi 83:988\u2013990","journal-title":"Yakugaku Zasshi"},{"key":"1947_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421\u2013433. https:\/\/doi.org\/10.1016\/j.cell.2012.01.017","journal-title":"Cell"},{"key":"1947_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/02713683.2015.1004719","volume":"41","author":"D Pirhan","year":"2016","unstructured":"Pirhan D, Y\u00fcksel N, Emre E, Cengiz A, K\u00fcr\u015fat Yildiz D (2016) Riluzole- and resveratrol-induced delay of retinal ganglion cell death in an experimental model of glaucoma. Curr Eye Res 41:59\u201369. https:\/\/doi.org\/10.3109\/02713683.2015.1004719","journal-title":"Curr Eye Res"},{"key":"1947_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-4274(01)00418-0","volume":"125","author":"B Piver","year":"2001","unstructured":"Piver B, Berthou F, Dreano Y, Lucas D (2001) Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 125:83\u201391. https:\/\/doi.org\/10.1016\/S0378-4274(01)00418-0","journal-title":"Toxicol Lett"},{"key":"1947_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","volume":"15","author":"NL Price","year":"2012","unstructured":"Price NL, Gomes AP, Ling AJY, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, De Cabo R, Baur JA, Sinclair DA (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675\u2013690. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.003","journal-title":"Cell Metab"},{"key":"1947_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1478-811X-9-11","volume":"9","author":"S Rahman","year":"2011","unstructured":"Rahman S, Islam R (2011) Mammalian Sirt1: insights on its biological functions. Cell Commun Signal 9:11. https:\/\/doi.org\/10.1186\/1478-811X-9-11","journal-title":"Cell Commun Signal"},{"key":"1947_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/CEO.12375","volume":"43","author":"N Razali","year":"2015","unstructured":"Razali N, Agarwal R, Agarwal P, Kumar S, Tripathy M, Vasudevan S, Crowston JG, Ismail NM (2015) Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension. Clin Exp Ophthalmol 43:54\u201366. https:\/\/doi.org\/10.1111\/CEO.12375","journal-title":"Clin Exp Ophthalmol"},{"key":"1947_CR54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/J.1753-4887.2008.00078.X","volume":"66","author":"M Rhone","year":"2008","unstructured":"Rhone M, Basu A (2008) Phytochemicals and age-related eye diseases. Nutr Rev 66:465\u2013472. https:\/\/doi.org\/10.1111\/J.1753-4887.2008.00078.X","journal-title":"Nutr Rev"},{"key":"1947_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/J.1749-6632.2010.05865.X","volume":"1215","author":"T Richard","year":"2011","unstructured":"Richard T, Pawlus AD, Igl\u00e9sias ML, Pedrot E, Waffo-Teguo P, M\u00e9rillon JM, Monti JP (2011) Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci 1215:103\u2013108. https:\/\/doi.org\/10.1111\/J.1749-6632.2010.05865.X","journal-title":"Ann N Y Acad Sci"},{"key":"1947_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/nu15102283","author":"U Rodella","year":"2023","unstructured":"Rodella U, Honisch C, Gatto C, Ruzza P, D\u2019Amato T\u00f3thov\u00e1 J (2023) Antioxidant nutraceutical strategies in the prevention of oxidative stress related eye diseases. Nutrients. https:\/\/doi.org\/10.3390\/nu15102283","journal-title":"Nutrients"},{"key":"1947_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/S11095-008-9723-Z","volume":"26","author":"P Roy","year":"2009","unstructured":"Roy P, Kalra N, Prasad S, George J, Shukla Y (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K\/AKT signaling pathways. Pharm Res 26:211\u2013217. https:\/\/doi.org\/10.1007\/S11095-008-9723-Z","journal-title":"Pharm Res"},{"key":"1947_CR44","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.jddst.2021.102480","volume":"63","author":"M Saha","year":"2021","unstructured":"Saha M, Saha DR, Ulhosna T, Sharker SM, Shohag MH, Islam MS, Ray SK, Rahman GS, Reza HM (2021) QbD based development of resveratrol-loaded mucoadhesive lecithin\/chitosan nanoparticles for prolonged ocular drug delivery. J Drug Deliv Sci Technol 63:102480. https:\/\/doi.org\/10.1016\/j.jddst.2021.102480","journal-title":"J Drug Deliv Sci Technol"},{"key":"1947_CR58","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_3204_22","author":"R Shetty","year":"2023","unstructured":"Shetty R, Joshi PD, Mahendran K, Jayadev C, Das D (2023) Resveratrol for dry eye disease\u2014hope or hype? Indian J Ophthalmol. https:\/\/doi.org\/10.4103\/IJO.IJO_3204_22","journal-title":"Indian J Ophthalmol"},{"key":"1947_CR59","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.fct.2014.04.023","volume":"69","author":"J Sim","year":"2014","unstructured":"Sim J, Jang HW, Song M, Kim JH, Lee SH, Lee S (2014) Potent inhibitory effect of alpha-viniferin on human cytochrome P450. Food Chem Toxicol 69:276\u2013280. https:\/\/doi.org\/10.1016\/j.fct.2014.04.023","journal-title":"Food Chem Toxicol"},{"key":"1947_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/ANNUREV-PHARMTOX-010611-134657\/CITE\/REFWORKS","volume":"54","author":"DA Sinclair","year":"2014","unstructured":"Sinclair DA, Guarente L (2014) Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol 54:363\u2013380. https:\/\/doi.org\/10.1146\/ANNUREV-PHARMTOX-010611-134657\/CITE\/REFWORKS","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1947_CR61","doi-asserted-by":"publisher","first-page":"17154","DOI":"10.3390\/MOLECULES191117154","volume":"19","author":"JM Smoliga","year":"2014","unstructured":"Smoliga JM, Blanchard O (2014) Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules 19:17154\u201317172. https:\/\/doi.org\/10.3390\/MOLECULES191117154","journal-title":"Molecules"},{"key":"1947_CR62","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S1734-1140(12)70948-9","volume":"64","author":"FG Soufi","year":"2012","unstructured":"Soufi FG, Mohammad-nejad D, Ahmadieh H (2012) Resveratrol improves diabetic retinopathy possibly through oxidative stress\u2014nuclear factor \u03baB\u2014apoptosis pathway. Pharmacol Rep 64:1505\u20131514. https:\/\/doi.org\/10.1016\/S1734-1140(12)70948-9","journal-title":"Pharmacol Rep"},{"key":"1947_CR63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.01.003","volume":"479","author":"N Summerlin","year":"2015","unstructured":"Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A (2015) Resveratrol nanoformulations: challenges and opportunities. Int J Pharm 479:282\u2013290. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.01.003","journal-title":"Int J Pharm"},{"key":"1947_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/J.1749-6632.2010.05844.X","volume":"1215","author":"T Szkudelski","year":"2011","unstructured":"Szkudelski T, Szkudelska K (2011) Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 1215:34\u201339. https:\/\/doi.org\/10.1111\/J.1749-6632.2010.05844.X","journal-title":"Ann N Y Acad Sci"},{"key":"1947_CR65","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.2174\/13816128113199990407","volume":"19","author":"J Tom\u00e9-Carneiro","year":"2013","unstructured":"Tom\u00e9-Carneiro J, Larrosa M, Gonz\u00e1lez-Sarr\u00edas A, Tom\u00e1s-Barber\u00e1n F, Garc\u00eda-Conesa M, Esp\u00edn J (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm des 19:6064\u20136093. https:\/\/doi.org\/10.2174\/13816128113199990407","journal-title":"Curr Pharm des"},{"key":"1947_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030269","author":"R Varela-Fern\u00e1ndez","year":"2020","unstructured":"Varela-Fern\u00e1ndez R, D\u00edaz-Tom\u00e9 V, Luaces-Rodr\u00edguez A, Conde-Penedo A, Garc\u00eda-Otero X, Luzardo-\u00e1lvarez A, Fern\u00e1ndez-Ferreiro A, Otero-Espinar FJ (2020) Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics12030269","journal-title":"Pharmaceutics"},{"key":"1947_CR67","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/01.CIR.0000029925.18593.5C","volume":"106","author":"T Wallerath","year":"2002","unstructured":"Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, F\u00f6rstermann U (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652\u20131658. https:\/\/doi.org\/10.1161\/01.CIR.0000029925.18593.5C","journal-title":"Circulation"},{"key":"1947_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-4274(01)00286-7","volume":"120","author":"P Walter","year":"2001","unstructured":"Walter P (2001) Towards ensuring the safety of vitamins and minerals. Toxicol Lett 120:83\u201387. https:\/\/doi.org\/10.1016\/S0378-4274(01)00286-7","journal-title":"Toxicol Lett"},{"key":"1947_CR69","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3109\/02713683.2015.1119282","volume":"41","author":"S Wang","year":"2016","unstructured":"Wang S, Moonasar N, Xiao X, Yin T, Weinreb RN, Sun X (2016) Effect of resveratrol-based nutritional supplement on choroidal thickness: a pilot study. Curr Eye Res 41:1339\u20131345.\u00a0https:\/\/doi.org\/10.3109\/02713683.2015.1119282","journal-title":"Curr Eye Res"},{"key":"1947_CR70","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/JAMA.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901. https:\/\/doi.org\/10.1001\/JAMA.2014.3192","journal-title":"JAMA"},{"key":"1947_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/J.1749-6632.2010.05854.X","volume":"1215","author":"JM Wu","year":"2011","unstructured":"Wu JM, Hsieh TC (2011) Resveratrol: a cardioprotective substance. Ann N Y Acad Sci 1215:16\u201321. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05854.x","journal-title":"Ann N Y Acad Sci"},{"key":"1947_CR72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.110.168724","volume":"335","author":"N Xia","year":"2010","unstructured":"Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, M\u00fcnzel T, F\u00f6rstermann U, Li H (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335:149\u2013154. https:\/\/doi.org\/10.1124\/jpet.110.168724","journal-title":"J Pharmacol Exp Ther"},{"key":"1947_CR73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2009.08.021","volume":"388","author":"Q Xu","year":"2009","unstructured":"Xu Q, Hao X, Yang Q, Si L (2009) Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem Biophys Res Commun 388:389\u2013394. https:\/\/doi.org\/10.1016\/j.bbrc.2009.08.021","journal-title":"Biochem Biophys Res Commun"},{"key":"1947_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.EJPHAR.2008.01.009","volume":"583","author":"YM Yang","year":"2008","unstructured":"Yang YM, Chen JZ, Wang XX, Wang SJ, Hu H, Wang HQ (2008) Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity. Eur J Pharmacol 583:148\u2013155. https:\/\/doi.org\/10.1016\/J.EJPHAR.2008.01.009","journal-title":"Eur J Pharmacol"},{"key":"1947_CR75","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s11064-015-1793-9","volume":"41","author":"K Zeng","year":"2016","unstructured":"Zeng K, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, Yang Y (2016) Resveratrol prevents retinal dysfunction by regulating glutamate transporters, glutamine synthetase expression and activity in diabetic retina. Neurochem Res 41:1050\u20131064. https:\/\/doi.org\/10.1007\/s11064-015-1793-9","journal-title":"Neurochem Res"},{"key":"1947_CR76","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1007\/S12035-016-9972-5","volume":"54","author":"K Zeng","year":"2017","unstructured":"Zeng K, Wang Y, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, Deng B, Wu X, Huang L, Yang Y (2017) Resveratrol inhibits diabetic-induced M\u00fcller cells apoptosis through microRNA-29b\/specificity protein 1 pathway. Mol Neurobiol 54:4000\u20134014. https:\/\/doi.org\/10.1007\/S12035-016-9972-5","journal-title":"Mol Neurobiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01947-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01947-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01947-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:05:30Z","timestamp":1761332730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01947-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01947-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review article is based on previously conducted studies and does not involve any human participants or animals, beyond their involvement in the previously published articles we cite. Therefore, no ethical approval and informed consent is required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"No publication enhancement materials were used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publication enhancement"}},{"value":"No third-party contents were used in our review article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permissions"}},{"value":"This is a review article; therefore, it does not require any trial registration.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}}]}}